ReviewCureus2026

Neuropsychiatric Effects of Glucagon-Like Peptide-1 Receptor Agonists in Schizophrenia-Spectrum Disorders: A Systematic Review.

Zakariya Y Alsanosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.